MicroRNA-204 increases sensitivity of neuroblastoma cells to cisplatin and is associated with a favourable clinical outcome
Published 2012 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
MicroRNA-204 increases sensitivity of neuroblastoma cells to cisplatin and is associated with a favourable clinical outcome
Authors
Keywords
-
Journal
BRITISH JOURNAL OF CANCER
Volume 107, Issue 6, Pages 967-976
Publisher
Springer Nature
Online
2012-08-15
DOI
10.1038/bjc.2012.356
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- miRNAs regulate SIRT1 expression during mouse embryonic stem cell differentiation and in adult mouse tissues
- (2016) Laura R. Saunders et al. Aging-US
- DNA demethylation increases sensitivity of neuroblastoma cells to chemotherapeutic drugs
- (2012) Jessica Charlet et al. BIOCHEMICAL PHARMACOLOGY
- VHL-Regulated MiR-204 Suppresses Tumor Growth through Inhibition of LC3B-Mediated Autophagy in Renal Clear Cell Carcinoma
- (2012) Olga Mikhaylova et al. CANCER CELL
- MiRNA-335 suppresses neuroblastoma cell invasiveness by direct targeting of multiple genes from the non-canonical TGF-β signalling pathway
- (2012) Jennifer Lynch et al. CARCINOGENESIS
- Inhibition of Neuroblastoma Tumor Growth by Targeted Delivery of MicroRNA-34a Using Anti-Disialoganglioside GD2 Coated Nanoparticles
- (2012) Amanda Tivnan et al. PLoS One
- miR-200bc/429 cluster modulates multidrug resistance of human cancer cell lines by targeting BCL2 and XIAP
- (2011) Wei Zhu et al. CANCER CHEMOTHERAPY AND PHARMACOLOGY
- MicroRNA-542-5p as a novel tumor suppressor in neuroblastoma
- (2011) Isabella Bray et al. CANCER LETTERS
- MicroRNAs 10a and 10b are potent inducers of neuroblastoma cell differentiation through targeting of nuclear receptor corepressor 2
- (2011) N H Foley et al. CELL DEATH AND DIFFERENTIATION
- miRNA Expression Profiling Enables Risk Stratification in Archived and Fresh Neuroblastoma Tumor Samples
- (2011) K. De Preter et al. CLINICAL CANCER RESEARCH
- Molecular mechanisms underlying the role of microRNAs (miRNAs) in anticancer drug resistance and implications for clinical practice
- (2011) Elisa Giovannetti et al. CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY
- Dysregulation of microRNA-204 mediates migration and invasion of endometrial cancer by regulating FOXC1
- (2011) T.K.H. Chung et al. INTERNATIONAL JOURNAL OF CANCER
- Chromosomal and MicroRNA Expression Patterns Reveal Biologically Distinct Subgroups of 11q- Neuroblastoma
- (2010) P. G. Buckley et al. CLINICAL CANCER RESEARCH
- Accurate prediction of neuroblastoma outcome based on miRNA expression profiles
- (2010) Johannes H. Schulte et al. INTERNATIONAL JOURNAL OF CANCER
- miR-181b modulates multidrug resistance by targeting BCL2 in human cancer cell lines
- (2010) Wei Zhu et al. INTERNATIONAL JOURNAL OF CANCER
- Direct and Coordinate Regulation of ATP-binding Cassette Transporter Genes by Myc Factors Generates Specific Transcription Signatures That Significantly Affect the Chemoresistance Phenotype of Cancer Cells
- (2010) Antonio Porro et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- MicroRNA-184 inhibits neuroblastoma cell survival through targeting the serine/threonine kinase AKT2
- (2010) Niamh H Foley et al. Molecular Cancer
- A MicroRNA Screen to Identify Modulators of Sensitivity to BCL2 Inhibitor ABT-263 (Navitoclax)
- (2010) L. T. Lam et al. MOLECULAR CANCER THERAPEUTICS
- Anti-GD2 Antibody with GM-CSF, Interleukin-2, and Isotretinoin for Neuroblastoma
- (2010) Alice L. Yu et al. NEW ENGLAND JOURNAL OF MEDICINE
- Recent Advances in Neuroblastoma
- (2010) John M. Maris NEW ENGLAND JOURNAL OF MEDICINE
- PI3K inhibitors prime neuroblastoma cells for chemotherapy by shifting the balance towards pro-apoptotic Bcl-2 proteins and enhanced mitochondrial apoptosis
- (2010) A Bender et al. ONCOGENE
- miR-204 is required for lens and retinal development via Meis2 targeting
- (2010) I. Conte et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Network Modeling Identifies Molecular Functions Targeted by miR-204 to Suppress Head and Neck Tumor Metastasis
- (2010) Younghee Lee et al. PLoS Computational Biology
- MYCN/c-MYC-induced microRNAs repress coding gene networks associated with poor outcome in MYCN/c-MYC-activated tumors
- (2009) P Mestdagh et al. ONCOGENE
- Widespread Dysregulation of MiRNAs by MYCN Amplification and Chromosomal Imbalances in Neuroblastoma: Association of miRNA Expression with Survival
- (2009) Isabella Bray et al. PLoS One
- miR-15b and miR-16 modulate multidrug resistance by targeting BCL2 in human gastric cancer cells
- (2008) Lin Xia et al. INTERNATIONAL JOURNAL OF CANCER
- The International Neuroblastoma Risk Group (INRG) Classification System: An INRG Task Force Report
- (2008) Susan L. Cohn et al. JOURNAL OF CLINICAL ONCOLOGY
- The role of microRNA expression pattern in human intrahepatic cholangiocarcinoma
- (2008) Lei Chen et al. JOURNAL OF HEPATOLOGY
- Antagomir-17-5p Abolishes the Growth of Therapy-Resistant Neuroblastoma through p21 and BIM
- (2008) Laura Fontana et al. PLoS One
- Distinctive microRNA signature of acute myeloid leukemia bearing cytoplasmic mutated nucleophosmin
- (2008) R. Garzon et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started